The Asia Pacific market for interventional oncology will expand through 2027, driven primarily by continued growth of cancer incidence, improving access to treatment, and the entry of new foreign and domestic competitors.
This Medtech 360 Report provides high-level market metrics for interventional oncology devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of Asia Pacific, across a 10-year period.
Table of contents
- Interventional Oncology Devices - Market Insights - Asia Pacific (Supplemental)
Author(s): Bishwjit Ghoshal, MBA
Bishwjit Ghoshal is an analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in interventional oncology and vascular access device markets. Bishwjit holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali.
Follow Bishwjit on twitter: @Bishwjit_DRG